glutathione conjugation mechanism

glutathione conjugation mechanism Phase II Drug Metabolism Scheme 1. Two pathways for

Name: glutathione conjugation mechanism Phase II Drug Metabolism Scheme 1. Two pathways for
Brand: www.alastairscarlett.com
SKU: 58717915350
Price: 21.97 USD
Availability: InStock
Rating: 4.7569 (5 reviews)

SKU: 58717915350

4.8

USD21.97 USD66.97

Pay in 4 interest-free payments of $5.49 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 28 - Aug 2

Description

In ferroptosis-targeted approaches, sorafenib, a System Xc-inhibitor, is undergoing a phase II trial in metastatic breast cancer, aiming to disrupt glutathione synthesis and thereby promote ferroptosis (NCT00101400)

It is structurally characterized and utilized in laboratory research settings for analytical and experimental evaluation under controlled conditions

It also helps to know why the noise is so loud in the first place

HUBERMAN: Why certain ones may be advantageous for certain purposes, of course, also highlighting the potential risks and in some case, outright dangers